Insider Transactions Reported by 13 Insiders of Intra-Cellular Therapies, Inc.

Location
Bedminster, NJ

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Intra-Cellular Therapies, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher D. Alafi Director $376,917,318 27 May 2021
RICHARD A. LERNER Director $7,161,162 30 Sep 2021
Lawrence J. Hineline SVP of Finance, CFO $372,319 07 Mar 2024
ROBERT L. VAN NOSTRAND Director $0 02 Apr 2025
Rory B. Riggs Director $0 02 Apr 2025
Suresh K. Durgam EVP, Chief Medical Officer $0 02 Apr 2025
Mark Neumann EVP, Chief Commercial Officer $0 02 Apr 2025
Eduardo Rene Salas Director $0 02 Apr 2025
Sharon Mates Chairman and CEO, Director $0 02 Apr 2025
Michael Halstead President $0 02 Apr 2025
Sanjeev Narula Executive Vice President & CFO $0 02 Apr 2025
JOEL S. MARCUS Director $0 02 Apr 2025
Michael Rawlins Director 09 Jun 2022

Recent Insider Transactions by Companies or Individuals for Intra-Cellular Therapies, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.